跳至主要内容
临床试验/JPRN-jRCT1032190068
JPRN-jRCT1032190068招募中2 期

A phase II clinical trial to examine the preventive effects of high humidity control on the patent ductus arteriosus - High humidity decreases symptomatic patent ductus arteriosus

Hirata Michisato0 个研究点目标入组 30 人开始时间: 2019年8月5日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 < 1age old(—)
性别
All

入选标准

  • Preterm infants at gestational weeks of 24 to 27 who admitted to neonatal intensive care unit at Yokohama city university medical center

排除标准

  • congenital abnormality
  • severe asphyxia (APGAR score 4 points or less at 5 minutes)
  • twin to twin transfusion syndrome apparent at birth
  • birth at another hospital
  • birth from underage and unmarried mother

研究者

发起方
Hirata Michisato

相似试验

招募中
2 期
Randomized phase II clinical study on preventive effects of GPS, healthy food on the incidence of infection cases in stomach and colon cancer patients before and after the abdominal surgerystomach and colon cancer patients
JPRN-UMIN000002343Research institute of cancer chemotherapy200
已完成
1 期
A phase I/II clinical trial of prophylactic extended-field radiotherapy of pelvic and para-aortic lymph nodes in locally advanced squamous cell carcinoma of the uterine cervix using carbon-ion beamsuterine cervical cancer
JPRN-UMIN000016169ational Institute of Radiological Sciences20
已完成
不适用
A Phase 2 clinical trial to evaluate the safety and efficacy of cone beam CT guided video assisted thoracoscopic partial resection for impalpable small pulmonary nodulesmalignant pulmonary nodule
JPRN-UMIN000030388General Thoracic Surgery, Chiba University Hospital20
进行中(未招募)
1 期
ABORL - A Phase II trial aiming to evaluate the clinical interest of ABEMACICLIB in patients with locally advanced/metastatic head and neck cancer harboring an homozygous deletion of CDKN2A, and/or an amplification of CCND1 and/or of CDK6 refractory to standards treatmentsPatients with locally advanced/metastatic head and neck cancer after failure of platinum and cetuximab or anti-EGFR-basedMedDRA version: 20.0Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2016-004537-25-FRCentre Léon Bérard25
进行中(未招募)
1 期
Treatment of advanced adenocarcinoma of the lungAdult patients with either firstly diagnosed or relapsed advanced adenocarcinoma of the lung harbouring ROS1 translocationMedDRA version: 17.1Level: LLTClassification code 10025032Term: Lung adenocarcinoma NOSSystem Organ Class: 100000004864
EUCTR2013-002737-38-ATniversity of Cologne30